Stereotaxis, Inc.
STXS · XNYSCIK 1289340fmd_1GF6MGMBVC0SZWSR77AMJQAVJ5Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2026, 66 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 32 | 31 | 29 | 29 | 27 | 35 | 28 | 27 | 27 | 32 |
| Cost of revenue | 8 | 11 | 6 | 6 | 8 | 12 | 10 | 12 | 12 | 15 |
| Net interest income | – | – | (0) | 0 | 0 | (0) | 0 | 1 | 1 | 1 |
| Gross profit | 25 | 20 | 24 | 23 | 19 | 23 | 18 | 15 | 15 | 17 |
| Research and development | 5 | 7 | 8 | 9 | 8 | 10 | 11 | 10 | 10 | 9 |
| Selling, general and administrative | 26 | 20 | 18 | 19 | 18 | 26 | 27 | 26 | 30 | 30 |
| Total operating expenses | 31 | 26 | 26 | 28 | 26 | 36 | 37 | 37 | 39 | 39 |
| Operating income | (6) | (6) | (2) | (5) | (7) | (13) | (19) | (22) | (25) | (22) |
| Interest expense | 2 | 0 | 0 | – | – | – | – | – | – | – |
| Interest and investment income | 0 | – | – | – | – | 0 | – | – | – | – |
| Other non-operating income (expense) | (2) | 0 | 3 | – | – | – | – | 0 | – | 0 |
| Net income | (5) | (6) | 0 | (5) | (7) | (11) | (18) | (21) | (24) | (22) |
| Net income to common shareholders | (12) | (7) | (1) | (6) | (8) | (12) | (20) | (22) | (25) | (23) |